Today on the Daily Dive is that of George Adams, CEO of Ventripoint Diagnostics (TSXV: VPT). Adams joins host Cassandra Leah to discuss the latest developments of the company, including the announcement that it is now working with veterinarians to address the needs of companion animals for echocardiography.
Ventripoint Diagnostics has become an industry leader in the application of Artificial Intelligence to echocardiography. The company’s VMS products provide accurate volumetric cardiac measurements equivalent to an MRI.
In layman terms, the company is able to accurately create a three dimensional model of a heart based on a two dimensional image produced via an echocardiogram. With the technology settled in the latest version of the product, the company has now begun selling the product to some of the world’s leading hospitals.
Sponsored · Antimony Resources
Catch the full video below.
FULL DISCLOSURE: Ventripoint Diagnostics is a client of Canacom Group, the parent company of The Deep Dive. The company has been compensated to cover Ventripoint Diagnostics on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
One Response
I’m a VPT shareholder and very much looking forward to seeing this Canadian medical technology company take to the world stage in the months and years ahead. Keep the news coming, Jay!